PTHL - Pheton Holdings Limited Analyst Forecast Prices

Corporate company logo of Pheton (PTHL)

The daily price chart for Pheton Holdings Ltd (PTHL) clearly demonstrates its status as an IT systems provider for the healthcare sector in China, where an expanding clinic base and digital patient monitoring support the 0.00 metric. The stability of the R&D division and the expertise of 3D modeling specialists eliminate personnel risks. The business relies on the implementation of specialized radiology software, which guarantees recurring revenue from service maintenance and licensing.

PTHL: Pheton Holdings Price Target Chart 09/06/2024 - 01/16/2026

Analytical breakdowns for Pheton Holdings Limited (PTHL)

- share price and expert price forecast:
- market capitalization statistics:
General company analysis:PTHL Pheton Holdings Ltd
Flagship merchandise of Pheton Holdings

Demand for high-precision brachytherapy systems from Pheton Holdings Ltd (PTHL) in Chinese clinics directly influences the professional community's revision of the business's fair value. The current consensus price target aggregates the weighted average expectations of experts, reflecting the market's valuation of the company's scale relative to its fundamentals, which allows investors to identify true catalysts for share price growth by analyzing the inflection points of this line.

Competitors of Pheton Holdings Ltd

HLN (Haleon PLC) - Fair Value Consensus|Kenvue Corp - Consensus Target|Fair Value Consensus VRNA|MENS - Price Target Chart|LGND (Ligand Pharmaceuticals) - Broker Consensus Forecast|AMRX (Amneal Pharmaceuticals Inc) - Consensus Target|Average Forecast Price Perrigo Company PLC (PRGO)|Price Target Chart Alvotech SA|Liquidia Technologies - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals) - Fair Value Consensus|Analyst Consensus Forecast MNKD (mannkindcorp.com)|Analyst Consensus Forecast Amphastar Pharmaceuticals Inc AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Corp)|theravance.com (TBPH) - Price Target Chart|Consensus Target Aquestive Therapeutics|SCPH (scPharma) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic Therapeutic|Consensus Target TNXP (Tonix Pharmaceuticals Inc.)|SXTC (SXT Pharmaceuticals) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc. (BHST) - Average Forecast Price|EXOZ: Consensus Target|oramed.com - Analyst Forecast Prices|ENTX: Analyst Consensus Forecast|MindWalk - Fair Value Consensus|ABVC (ABVC BioPharma Inc.) - Analyst Consensus Forecast|Average Forecast Price cumberlandpharma.com CPIX|Price Target Chart Quantum BioPharma (QNTM)|FGEN (FibroGen) - Fair Value Consensus|Telomir Pharmaceuticals, Inc. - Consensus Target|Fair Value Consensus RANI|SNYR: Consensus Target|RLYB - Analyst Consensus Forecast|LEXX (Lexaria Bioscience) - Consensus Target|PULM (Pulmatrix Inc) - Price Target Chart|Price Target Chart aptorumgroup.com|Analyst Consensus Forecast Lyra Therapeutics, Inc.|Consensus Target IBO (Impact BioMedical Inc)|TNFA: Forecast Levels Chart|cbdMD, Inc. - Consensus Target|PainReform (PRFX) - Average Forecast Price|CYTO - Price Target Chart|LIPO - Analyst Consensus Forecast|OPTN: Analyst Consensus Forecast|Forecast Levels Chart PIRS (Pieris Pharmaceuticals)|PROC (procapsgroup.com) - Analyst Consensus Forecast|PTPI: Fair Value Consensus|Analyst Consensus Forecast QLI|Analyst Median Target ACELYRIN Inc.|Analyst Consensus Forecast TFFP (tffpharma.com)